|
|
Article: Luminex Receives FDA Clearance for an Update to the xTAG[R] Respiratory Viral Panel Package Insert.
- Article from:
- Business Wire
- Article date:
- July 14, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Package Insert to Include Data from Two New Publications on 2009 Influenza A/H1N1
AUSTIN, Texas -- Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared labeling updates for the company's xTAG[R] Respiratory Viral Panel (RVP) to include data about the performance of the test in humans infected with the pandemic strain of influenza A, 2009 influenza A/H1N1, which is sometimes referred to as "swine flu." The test's labeling has been updated to include information from two new studies that demonstrate that xTAG RVP can be an effective aid in the detection of ...